Log in
Enquire now
‌

US Patent 8962593 GLA monotherapy for use in cancer treatment

Patent 8962593 was granted and assigned to Immune Design on February, 2015 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
Immune Design
Immune Design
0
Current Assignee
Immune Design
Immune Design
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
89625930
Patent Inventor Names
Carlos V. Paya Cuenca0
Jan Henrik Ter Meulen0
Date of Patent
February 24, 2015
0
Patent Application Number
143337580
Date Filed
July 17, 2014
0
Patent Primary Examiner
‌
Traviss C Mcintosh, III
0
Patent abstract

The present disclosure relates generally to compositions and methods for treating cancer with a glucopyranosyl lipid A (GLA) in the absence of antigen.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 8962593 GLA monotherapy for use in cancer treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us